Latest in Tapestry’s Stock Climbs
Sort by
771 items
-
Viking Therapeutics’ weight-loss pill shows ‘great outcome’ in trial
The stock, which enjoys the unusual position of having all buy ratings from the 13 analysts offering coverage on FactSet, has been on a tear this year, gaining 270% to date in 2024.Business - MarketWatch - November 4 -
Here’s the big barrier Amazon stock must overcome to reach fresh highs
There is a fundamental reason why the shares have been rebuffed at the $200 markBusiness - MarketWatch - November 4 -
Stock-market investors should treat Trump and Harris election playbooks with caution
Wall Street makes trading elections sound as easy as falling off a log. Reality often disappoints.Business - MarketWatch - November 4